# Research Purposes > any purpose except commercialisation, i.e. licensing for value or sale for value OR acts done for experimental purposes or to obtain regulatory approval **Term:** Research Purposes **Last updated:** 2026-07-29 ## Definition ## What Research Purposes Means in a Contract Research Purposes is a defined term used to carve out a category of activity that a party may undertake with materials, data, technology, or intellectual property without triggering commercial obligations such as royalties, licence fees, or sale restrictions. The core idea is negative: it is defined by what it excludes, namely commercialisation. If an activity involves licensing for value or sale for value, it falls outside Research Purposes. If it involves experimentation or steps taken to secure regulatory approval, including running a clinical trial, it falls inside the definition. This structure is common in agreements where one party grants access to something valuable, such as a compound, dataset, or piece of software, but wants to distinguish between a recipient who is testing or studying that item and a recipient who is trying to monetise it. The distinction matters because many agreements attach different rights, fees, and liabilities depending on which category applies. A party using something for Research Purposes typically enjoys more relaxed terms because the risk of competitive harm or lost revenue to the grantor is lower. The term is especially prevalent in life sciences and pharmaceutical contracts, but it also appears in technology licensing, academic collaborations, and data-sharing arrangements. Wherever a grantor wants to permit exploration without permitting profit, Research Purposes offers a ready-made boundary line. ## How Research Purposes Is Defined or Measured The definition typically works as a two-part test. First, the activity must not constitute commercialisation, which is usually described as licensing for value or sale for value. Second, the activity must positively fall within one of the permitted categories: experimental work, or efforts to obtain regulatory approval for a generic or innovative medicinal product, including any clinical trial. Both limbs are usually needed for the definition to apply cleanly. In practice, measuring whether an activity qualifies requires looking at the purpose and outcome of the work, not merely its label. A party cannot simply call a commercial pilot programme research if the underlying intent is to generate revenue or secure a paying customer. Conversely, legitimate feasibility studies, laboratory testing, and trial-related data collection generally sit comfortably within the definition even if the eventual product will one day be sold. - Absence of any sale or licence fee attached to the immediate activity - Presence of an experimental, investigative, or testing element - A connection to regulatory approval processes, such as clinical trials for medicinal products Contracts sometimes supplement this core definition with examples or exclusions to reduce ambiguity, particularly where the boundary between research and early commercialisation is likely to be contested. ## Where Research Purposes Appears in Agreements The term most often appears in licensing and collaboration documents, including materials transfer agreements, data licensing agreements, and clinical trial agreements. It is a fixture of any [licensing agreement](https://www.genieai.co/en-us/template-type/licensing-agreement) that grants a narrower, non-commercial right alongside a separate commercial licence structure. It also features heavily in a [research agreement](https://www.genieai.co/en-us/template-type/research-agreement) or a broader [research and development agreement](https://www.genieai.co/en-us/template-type/research-and-development-agreement), where the parties need to describe permitted uses of shared data, samples, or background intellectual property. Universities, contract research organisations, and pharmaceutical sponsors rely on this language to keep collaborative work within agreed bounds. Beyond life sciences, the concept surfaces in technology sectors where a vendor allows evaluation or testing of software or hardware without triggering a full commercial licence, and in the [healthcare](https://www.genieai.co/industry/healthcare) industry where regulatory approval pathways are central to how products move from testing to market. ## Why the Exact Wording Matters Because the definition hinges on excluding commercialisation, imprecise wording can create real disputes. If licensing for value is not clearly described, a party might argue that an internal cross-charge or a sublicence to an affiliate still qualifies as research use. Similarly, if the regulatory approval limb is too narrow, activities that support but do not directly constitute a clinical trial could fall outside the protection the parties intended. The stakes are highest in pharmaceutical and biotechnology contracts, where the line between research and commercial exploitation can determine whether royalties are owed, whether a licence converts to a commercial one, or whether a breach has occurred. Ambiguity here can delay regulatory submissions or expose a party to unexpected liability under the law governing the contract. ## Drafting Considerations Drafters should ensure the two limbs of the definition, the commercialisation exclusion and the permitted research activities, are both clearly and consistently worded throughout the agreement. It helps to cross-reference other defined terms such as Commercialisation, Licensed Product, or Field of Use so the boundaries align rather than conflict. Consider whether the definition needs to address activities that straddle research and early commercial testing, such as pilot manufacturing runs or paid feasibility studies. Adding illustrative examples or explicit carve-outs can reduce future disagreement. Finally, parties should think about who bears responsibility for regulatory filings and clinical trial conduct, since the Research Purposes definition often interacts directly with representations, indemnities, and termination rights tied to regulatory approval outcomes. ## Context ### Relevant circumstances - When materials or IP are licensed for non-commercial use only - If clinical trials or regulatory submissions are within scope of permitted use - Where the boundary between research and commercialisation must be drawn ### Relevant sectors - Healthcare ## Relevant contract types - [Licensing Agreement](https://www.genieai.co/en-us/template-type/licensing-agreement) - [Research Agreement](https://www.genieai.co/en-us/template-type/research-agreement) - [Research and Development Agreement](https://www.genieai.co/en-us/template-type/research-and-development-agreement) --- This is the Markdown representation of [https://www.genieai.co/en-us/define/research-purposes](https://www.genieai.co/en-us/define/research-purposes), provided for AI agents and crawlers. The HTML page is canonical. See [/llms.txt](https://www.genieai.co/llms.txt) for the full content map.